Zobrazeno 1 - 10
of 715
pro vyhledávání: '"S A, Orlov"'
Autor:
Y. V. Belysheva, E. K. Bakaeva, A. R. Venina, A. A. Romanko, G. A. Raskin, A. P. Sokolenko, E. N. Suspitsin, A. A. Avetisyan, S. V. Orlov, E. N. Imyanitov
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 6, Pp 83-91 (2024)
The aim of the study was to compare the spectra of pathogenic BRCA1 and BRCA2 variants in patients with hereditary breast cancer (BC) and ovarian cancer (OC) from two groups of ethnic Armenians: Yerevan and cities of southern Russia.Material and Meth
Externí odkaz:
https://doaj.org/article/fba47bd88bee4bc68054576336395c77
Autor:
O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, S. A. Berns, A. V. Budnevsky, V. V. Gainitdinova, A. A. Garanin, V. M. Gorbunov, A. Yu. Gorshkov, E. A. Grigorenko, B. Yu. Jonova, L. Yu. Drozdova, I. V. Druk, S. O. Eliashevich, M. S. Eliseev, G. Zh. Zharylkasynova, S. A. Zabrovskaya, A. E. Imaeva, U. K. Kamilova, A. D. Kaprin, Zh. D. Kobalava, D. V. Korsunsky, O. V. Kulikova, A. S. Kurekhyan, N. P. Kutishenko, E. A. Lavrenova, M. V. Lopatina, Yu. V. Lukina, M. M. Lukyanov, E. O. Lyusina, M. N. Mamedov, B. U. Mardanov, Yu. V. Mareev, S. Yu. Martsevich, N. P. Mitkovskaya, R. P. Myasnikov, D. V. Nebieridze, S. A. Orlov, K. G. Pereverzeva, O. E. Popovkina, V. I. Potievskaya, I. A. Skripnikova, M. I. Smirnova, T. M. Sooronbaev, N. V. Toroptsova, Zh. V. Khailova, V. E. Khoronenko, M. G. Chashchin, T. A. Chernik, S. A. Shalnova, M. M. Shapovalova, R. N. Shepel, A. F. Sheptulina, V. N. Shishkova, R. U. Yuldashova, I. S. Yavelov, S. S. Yakushin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 3 (2024)
Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.
Externí odkaz:
https://doaj.org/article/be1bf718a83641c9bbdec3186ac2921b
Autor:
S. V. Russkikh, E. A. Tarasenko, L. I. Moskvicheva, S. A. Orlov, A. A. Tryakin, A. V. Vorobeva, O. A. Beneslavskaya, V. I. Makarova, E. A. Putilina, S. A. Utkin
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 2, Pp 149-160 (2023)
The aim of the work was to analyze Russian and foreign experience in the regulation and application practice of “off-label” drugs in order to develop recommendations on the optimization of their application in clinical practice.Material and metho
Externí odkaz:
https://doaj.org/article/1147e4fc6d9a4fde8c1eee03e01db034
Autor:
I. S. Polyakov, V. A. Porhanov, A. L. Kovalenko, I. V. Gilevich, O. N. Ponkina, V. S. Zima, D. D. Karal-ogly, S. V. Orlov, A. S. Sotnichenko, A. G. Zavgorodnyaya
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 30, Iss 1, Pp 27-36 (2023)
Introduction. Bronchial fistula often occurs after lung surgery. This is an extremely severe complication with high mortality. Despite the variety methods for the treatment of bronchial fistula, the results are not always effective. In our paper, we
Externí odkaz:
https://doaj.org/article/b50a47a66ead42b894880b3f8ae12659
Autor:
K. A. Oganyan, A. A. Musaelyan, S. V. Lapin, T. V. Kupenskaya, A. A. Sveсhkova, M. A. Belyaev, A. A. Zakharenko, S. V. Orlov
Publikováno v:
Успехи молекулярной онкологии, Vol 10, Iss 1, Pp 40-48 (2023)
Introduction. Perioperative FLOT chemotherapy has improved prognosis in patients with locally advanced resectable gastric cancer (GC). However, in 80 % of cases, the tumor is resistant to the therapy, resulting in unnecessary toxicity and delayed sur
Externí odkaz:
https://doaj.org/article/48b169fc192947978f9fe44ea90a9f2d
Autor:
S. A. Orlov, R. N. Shepel, D. V. Voshev, D. O. Savchenko, D. A. Gellekh, А. B. Gorlov, K. S. Mezhidov, M. V. Turlay, A. V. Sentsova, L. M. Zhamalov, A. V. Kontsevaya, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 9S (2023)
The distribution of publications posted in the Elibrary for the period from January 1, 2012 to December 31, 2022, in the structure of a cognitive matrix of taxonomic characteristics for the analysis and assessment of primary health care in the Russia
Externí odkaz:
https://doaj.org/article/7e1f1d853ca64d50be243013f4720f00
Autor:
D. V. Voshev, I. M. Son, N. A. Vosheva, S. A. Orlov, K. S. Mezhidov, R. N. Shepel, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 9S (2023)
Aim. To analyze digital technologies in the primary health care system, as well as studying the impact of digital health literacy on patient satisfaction with the services provided.Material and methods. A study assessing patients' opinions on the dig
Externí odkaz:
https://doaj.org/article/cc836783a71c45c4bb790e8061530763
Autor:
E. V. Levchenko, F. V. Moiseenko, S. V. Orlov, E. N. Imyanitov, A. E. Mikhnin, M. L. Gelfond, E. N. Slugin, S. M. Ergnyan, N. E. Levchenko, A. S. Zhabina, A. M. Ulitin, O. Yu. Mamontov, O. O. Lopushanskaya, E. V. Artemeva, A. I. Murtazin, V. I. Shabinskaya
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 5-14 (2023)
Objective. To assess the overall and disease-free survival rates in patients with EGFR-mutated lung adenocarcinoma, who underwent surgery after achieving the objective response to tyrosine kinase inhibitor (TKI) therapy.Material and Methods. The over
Externí odkaz:
https://doaj.org/article/7336c9ed20724b46b7c9eb818dc1a744
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 2, Pp 71-78 (2022)
Introduction. Fine needle aspiration biopsy followed by cytological examination is the gold standard in the diagnosis of thyroid nodules. However, up to one third of cases represent an indeterminate result (Bethesda Thyroid Classification, 2017) III
Externí odkaz:
https://doaj.org/article/bda8c49f56f341f692685f4c13d6a75d
Autor:
A. A. Musaelyan, S. V. Lapin, M. A. Urtenova, S. V. Odintsova, I. V. Chistyakov, A. M. Ulitin, N. T. Ismanbaev, A. L. Akopov, S. V. Orlov
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 2, Pp 79-88 (2022)
Itroduction. Immune checkpoint inhibitors have become the standard of care for patients with advanced non-small cell lung cancer. However, despite the determination of programmed death-ligand 1 expression in clinical practice, which determines the ef
Externí odkaz:
https://doaj.org/article/3ad6732d802f458d83f8727e411fce75